Corcept Therapeutics Securities Class Action Lawsuit
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Corcept Therapeutics · Corcept Therapeutics securities · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Corcept Therapeutics
- Product or service
- Corcept Therapeutics securities
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
Participation information
Availability is based on each listed participation option and its deadline.
Lead Plaintiff Application
Shareholders who purchased Corcept shares from October 31, 2024 through December 30, 2025 and suffered a loss.
Contact DJS Law Group regarding possible appointment as lead plaintiff. Appointment as lead plaintiff is not required to participate in any recovery.
- Type
- Lead Plaintiff
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Corcept Therapeutics Securities Class Action Lawsuit
Benzinga ·
- Corcept Therapeutics Securities Class Action
Barchart.com ·
- Corcept Therapeutics Securities Fraud Class Action
Barchart.com ·